ARTICLE | Clinical News
AVI-5038 regulatory update
January 4, 2010 8:00 AM UTC
EMEA's Committee for Orphan Medical Products (COMP) granted Orphan Drug designation to AVI-5038 to treat Duchenne muscular dystrophy (DMD). The neugene antisense oligonucleotide targeting exon 50 of ...